


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-1.89%
+1.28%
+6.87%
MLYS
Mineralys Therapeutics
$27.60
Strengths

Earnings are forecast to grow
Technical Indicators

Crossed Below 200 DMA
MLYS Price Performance
$31.93 (-13.56%)
$42.12 (-34.47%)
$37.65 (-26.69%)
$9.92 (+178.23%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
MLYS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
MLYS Street Sentiment is bullish and have positive views on the near-term outlook
MLYS has Low risk level

Average key support and resistance price levels
Recent Upgrades and Downgrades
STRONG BUY
Date
Action
Rating
Firm
Nov 12, 2025
Reiterate
Buy
HC Wainwright & Co.
Nov 12, 2025
Reiterate
Overweight
Wells Fargo
Oct 30, 2025
Reiterate
Buy
HC Wainwright & Co.
LLY
Eli Lilly and
1040.00
+0.35%
IXHL
Incannex Healthcare Inc.
0.27
+0.04%
What is MLYS current stock price?
What are MLYS stock strengths?
What is MLYS Risk Level?
What is MLYS market cap and volume?
What is MLYS current Stock IQ?
Should I buy MLYS stock right now?
Is MLYS a Strong Buy right now?
What does a 'Strong Buy' rating mean for MLYS?
What does a 'Strong Sell' rating mean for MLYS?
What factors influence MLYS's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-1.89%
+1.28%
+6.87%
MLYS
Mineralys Therapeutics
Current Price
$27.60
Runners Also Watch
LLY
Eli Lilly and
1040.00
+0.35%
IXHL
Incannex Healthcare Inc.
0.27
+0.04%

MLYS Price Performance
$31.93 (-13.56%)
$42.12 (-34.47%)
$37.65 (-26.69%)
$9.92 (+178.23%)
MLYS Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
MLYS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
MLYS Street Sentiment is bullish and have positive views on the near-term outlook
MLYS has Low risk level

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Nov 12, 2025
Reiterate
Buy
HC Wainwright & Co.
Nov 12, 2025
Reiterate
Overweight
Wells Fargo
Oct 30, 2025
Reiterate
Buy
HC Wainwright & Co.
MLYS Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow
Technical Indicators

Crossed Below 200 DMA
MLYS Latest Analysis
Mineralys Therapeutics Breaks Below 200-Day Moving Average - Notable for MLYS. In trading on Friday shares of Mineralys Therapeutics Inc (Symbol: MLYS) crossed below their 200 day moving average of $27.66 changing hands as low as $27.33 per share. Mineralys Therapeutics Inc shares are currently trading up about 1.5% on the day. The chart below shows th
Fri Feb 13, 2026
Mineralys Therapeutics (MLYS) Files Lorundrostat NDA Following Positive Clinical Milestones. Mineralys Therapeutics Inc. (NASDAQ:MLYS) is one of the best high short interest stocks with biggest upside potential. On January 6 Mineralys Therapeutics announced the late 2025 filing of its NDA for lorundrostat. The company highlighted several clinical milestones including the completion of three positive trials (Explore-CKD Launch-HTN and Advance-HTN) which demonstrated the drugs 24-hour blood [̷
Fri Jan 30, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
MLYS Stock trends
MLYS Stock performance
MLYS Stock analysis
MLYS investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.